Literature DB >> 34072436

Reactivation of Multiple Fetal miRNAs in Lung Adenocarcinoma.

David E Cohn1, Mateus C Barros-Filho1,2, Brenda C Minatel1, Michelle E Pewarchuk1, Erin A Marshall1, Emily A Vucic1,3, Adam P Sage1, Nikita Telkar1,4,5, Greg L Stewart1, Igor Jurisica6,7,8,9, Patricia P Reis10, Wendy P Robinson4,5, Wan L Lam1.   

Abstract

MicroRNAs (miRNAs) play vital roles in the regulation of normal developmental pathways. However, cancer cells can co-opt these miRNAs, and the pathways that they regulate, to drive pro-tumourigenic phenotypes. Characterization of the miRNA transcriptomes of fetal organs is essential for identifying these oncofetal miRNAs, but it has been limited by fetal sample availability. As oncofetal miRNAs are absent from healthy adult lungs, they represent ideal targets for developing diagnostic and therapeutic strategies. We conducted small RNA sequencing of a rare collection of 25 human fetal lung (FL) samples and compared them to two independent cohorts (n = 140, n = 427), each comprised of adult non-neoplastic lung (ANL) and lung adenocarcinoma (LUAD) samples. We identified 13 oncofetal miRNAs that were expressed in FL and LUAD but not in ANL. These oncofetal miRNAs are potential biomarkers for LUAD detection (AUC = 0.963). Five of these miRNAs are derived from the imprinted C14MC miRNA cluster at the 14q32 locus, which has been associated with cancer development and abnormal fetal and placental development. Additionally, we observed the pulmonary expression of 44 previously unannotated miRNAs. The sequencing of these fetal lung samples also provides a baseline resource against which aberrant samples can be compared.

Entities:  

Keywords:  lung adenocarcinoma; microRNA; novel microRNA; oncofetal

Year:  2021        PMID: 34072436     DOI: 10.3390/cancers13112686

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  40 in total

Review 1.  DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.

Authors:  Jhon R Enterina; Katey S S Enfield; Christine Anderson; Erin A Marshall; Kevin W Ng; Wan L Lam
Journal:  Expert Rev Respir Med       Date:  2017-07-20       Impact factor: 3.772

2.  Circos: an information aesthetic for comparative genomics.

Authors:  Martin Krzywinski; Jacqueline Schein; Inanç Birol; Joseph Connors; Randy Gascoyne; Doug Horsman; Steven J Jones; Marco A Marra
Journal:  Genome Res       Date:  2009-06-18       Impact factor: 9.043

3.  miR-Test: a blood test for lung cancer early detection.

Authors:  Francesca Montani; Matteo Jacopo Marzi; Fabio Dezi; Elisa Dama; Rose Mary Carletti; Giuseppina Bonizzi; Raffaella Bertolotti; Massimo Bellomi; Cristiano Rampinelli; Patrick Maisonneuve; Lorenzo Spaggiari; Giulia Veronesi; Francesco Nicassio; Pier Paolo Di Fiore; Fabrizio Bianchi
Journal:  J Natl Cancer Inst       Date:  2015-03-19       Impact factor: 13.506

4.  MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/β-catenin signaling via targeting Glypican-5.

Authors:  Xin Hong; Zhengliang Zhang; Longfei Pan; Wei Ma; Xu Zhai; Changwei Gu; Yaru Zhang; Xiaoju Bi; Wan Huang; Honghong Pei; Zhong Liu
Journal:  Eur J Pharmacol       Date:  2019-04-03       Impact factor: 4.432

Review 5.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

6.  MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Authors:  Zhi-Li Liu; He Wang; Jing Liu; Zhao-Xia Wang
Journal:  Mol Cell Biochem       Date:  2012-09-06       Impact factor: 3.396

7.  Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.

Authors:  Sang Joon Park; Jae Young Jang; Soung Won Jeong; Young Kyu Cho; Sae Hwan Lee; Sang Gyune Kim; Sang-Woo Cha; Young Seok Kim; Young Deok Cho; Hong Soo Kim; Boo Sung Kim; Suyeon Park; Hae In Bang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.

Authors:  Katherine E Hill; Andrew D Kelly; Marieke L Kuijjer; William Barry; Ahmed Rattani; Cassandra C Garbutt; Haydn Kissick; Katherine Janeway; Antonio Perez-Atayde; Jeffrey Goldsmith; Mark C Gebhardt; Mohamed S Arredouani; Greg Cote; Francis Hornicek; Edwin Choy; Zhenfeng Duan; John Quackenbush; Benjamin Haibe-Kains; Dimitrios Spentzos
Journal:  J Hematol Oncol       Date:  2017-05-15       Impact factor: 17.388

9.  Prioritizing and selecting likely novel miRNAs from NGS data.

Authors:  Christina Backes; Benjamin Meder; Martin Hart; Nicole Ludwig; Petra Leidinger; Britta Vogel; Valentina Galata; Patrick Roth; Jennifer Menegatti; Friedrich Grässer; Klemens Ruprecht; Mustafa Kahraman; Thomas Grossmann; Jan Haas; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2015-12-03       Impact factor: 16.971

10.  Novel microRNA discovery using small RNA sequencing in post-mortem human brain.

Authors:  Christian Wake; Adam Labadorf; Alexandra Dumitriu; Andrew G Hoss; Joli Bregu; Kenneth H Albrecht; Anita L DeStefano; Richard H Myers
Journal:  BMC Genomics       Date:  2016-10-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.